Development and characterization of once a daily tablet formulation of aceclofenac

International Journal of Pharmaceutical Research

Volumn 2, Issue 4, 2010, Pages 56-61

  Parejiya, Punit B ^a   Barot, Bhavesh S ^a   Patel, Hetal K ^a   Shelat, Pragna K ^a  

^a K B INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Aceclofenac; Dissolution efficiency; Kollidon SR; Model fitting; Senafen

Indexed keywords

ACECLOFENAC; KOLLIDON SR; POVIDONE; UNCLASSIFIED DRUG;

ARTICLE; DRUG SOLUBILITY; DRUG STABILITY; IONIC STRENGTH; PH; PHYSICAL CHEMISTRY; SUSTAINED DRUG RELEASE; TABLET COMPRESSION; TABLET FORMULATION; TABLET MANUFACTURE; TABLET MATRIX;

EID: 79952085931     PISSN: None     EISSN: 09752366     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Amidon G.L., Lobenberg R. Modern bioavailability bioequivalence and biopharmaceutics classification system: new scientific approaches to international regulatory standards, Eur. J. Pharm. Biopharm., 2000; 50 (2):3-12.
2. Ford J.L., Rubinstein M.H., Hogan J.E. Formulation of sustained-release promethazine hydrochloride tablets using hydroxypropyl methyl cellulose matrixes, Int. J. Pharm., 1985; 24: 327-338.
3. Reddy R.K., Mutalik S., Reddy S. Once daily sustained release matrix tablets of nicorandil: formulation and in vitro evaluation, Pharm. Sci. Tech., 2003; 4(4):25-29.
4. Chien Y. W. Regulatory considerations in controlled release medication. In Y. W. Chien, editors, Novel Drug Delivery Systems, Marcel Dekker, New York, NY, 1982;577-578.
5. Terashita K. and Imamura K., Preparation of antipyretic analgesic by direct compression and its evaluation, Chem. Pharm. Bull., 2002; 12:1542-1549.
6. Lordi G.N., Sustained release dosage forms, In: Lachman L., Lieberman H. A., Kanig J. L., editors. The Theory and Practice of Industrial Pharmacy, third edition, New Delhi; Varghese Publishing House; 1991:442-454.
7. Parfitt K. Analgesics anti-inflammatory and antipyretics, In: Reynolds J.E.F, editors. Martindale: The Complete Drug Reference: 1999: 2-12
8. Lieberman H.A., Lachman L. and Schwartz J. B. Pharmaceutical Dosage Forms: Tablets, Vol. 2, second edition. New York: Marcel Dekker; 1990:201-243.
9. The United State Pharmacopoeia 24, NF 19, United State pharmacopoeial convention, Rockville, M.D. Asian Edi., 2000;1462-5, 1913-4
10. Costa P., Manuel J. Modeling and comparison of dissolution profiles, Eur.J. Pharm. Sci., 2001; 13: 123-133.
11. Banakar U.V. Pharmaceutical Dissolution Testing. New York, NY: Marcel Dekker Inc; 1992.
12. 2 factorial design. Drug. Dev. Ind. Pharm., 2002; 28: 77-87.
13. Bamba M., Puisievx F., Marty J., Carstensen J. Release mechanism in gel forming sustained release formulation, Int. J. Pharm.,1979; 2(5-6):307-315.
14. Gibaldi M., Feldman S. Establishment of sink conditions in dissolution rate determination. J. Pharm. Sci., 1967; 56 (10): 1238-1242.
15. Korsmeyer R., Gurny R., Doelker E. Buri P., Peppas N. Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm.,1983; 15(1):25-35.
16. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspensions, J. Pharm. Sci., 1961; 50(10):874-875
17. Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci., 1963; 52(12):1145-1149.
18. Higuchi I. Analysis of data on the medicament release from ointments. J. Pharm. Sci., 1962; 51(8):802-804.
19. Langenbucher F. Linearization of dissolution rate curves by the weibull distribution, J. Pharm. Pharmacol., 1972; 24(12):979-989.
20. Atul Kuksal, Ashok K. Tiwary, Narendra K. Jain, and Subheet Jain. Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of zidovudine: influence of combination of hydrophilic and hydrophobic matrix formers. AAPS Pharm. Sci. Tech. 2006; 7 (1):1-9.
21. Reza M.S., Abdul Quadir M., Haider S.S. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlledrelease drug delivery. J. Pharm. Pharm. Sci. 2003; 6: 282-291.
22. Patil S.A., Kuchekar B.S., Chabukswar A.R., Jagdale J.C. Formulation and evaluation of extended-release solid dispersion of metformin hydrochloride, J. Young. Pharm., 2010; 2(2):121-129.
23. Khan K. A. The concept of dissolution efficiency, J. Pharm Pharmacol, 1975; 27: 48-49.
24. Ansar M., Kazemipour M., Talebnia J. The development and validation of a dissolution method for clomipramine solid dosage forms. Dissolution Technologies, 2004; 11(3):16-24.